Disease & disorder

tuberculosis

MONDO:0018076

A chronic, recurrent infection caused by the bacterium Mycobacterium tuberculosis. Tuberculosis (TB) may affect almost any tissue or organ of the body with the lungs being the most common site of infection. The clinical stages of TB are primary or initial infection, latent or dormant infection, and recrudescent or adult-type TB. Ninety to 95% of primary TB infections may go unrecognized. Histopathologically, tissue lesions consist of granulomas which usually undergo central caseation necrosis. Local symptoms of TB vary according to the part affected; acute symptoms include hectic fever, sweats, and emaciation; serious complications include granulomatous erosion of pulmonary bronchi associated with hemoptysis. If untreated, progressive TB may be associated with a high degree of mortality. This infection is frequently observed in immunocompromised individuals with AIDS or a history of illicit IV drug use.

Clinical trials303
Recruiting13
Drug concepts studied20
Synonyms4

Research intelligence

Directly mapped studies only · unique clinical trials

Current registry observations. Phase counts may overlap. Study start dates are not registry registration dates. Investigational interventions are not approved-treatment recommendations.

Medications under investigation

Verified disease and drug mappings that co-occur within the same study; not evidence of effectiveness.

Loading mapped interventions…

MONDO disease family

Loading verified ontology relationships…

Recruiting studies by city

Loading research-site locations…

Trial status

Loading…

Trial phase

Loading…

Study start year

Loading…

Investigated drug interventions

Loading…

Clinical trials

40 shown
Peer-led Implementation of TB-HIV Education and Adherence Counseling in UgandaNCT05917210 · 2026-03-16
RECRUITING
Dolutegravir/Lamivudine Dual Therapy for ART-naïve People With HIV and TB Receiving Rifampin-based TB TreatmentNCT06497465 · 2025-09-18
RECRUITING
Questioning the Epidemiology of Asymptomatic TBNCT07312266 · 2025-08-11
RECRUITING
The DECIDE-TB Trial; Validation of Treatment Decision Algorithms for Childhood TuberculosisNCT06593080 · 2024-06-01
RECRUITING
Assessing the Feasibility of Coach Mpilo for Men With TB and HIVNCT07117370 · 2024-06-01
RECRUITING
Advice of Moderate Drinking Pattern Versus Advice on Abstention on Major Disease and MortalityNCT06338215 · 2024-05-15
RECRUITING
Mediastinal EBUS Cryobiopsy Study In SwedenNCT06347939 · 2024-04-01
RECRUITING
South Africa Smoking Cessation and Engagement in HIV/TB Care CareNCT05842161 · 2024-03-12
RECRUITING
Evaluating the Safety and Immunogenicity of MTBVACNCT05947890 · 2024-01-30
RECRUITING
Doxycycline Host-directed Therapy to Improve Lung Function and Decrease Tissue Destruction in Pulmonary TuberculosisNCT05473520 · 2023-05-24
RECRUITING
Efficacy, Safety and Immunogenicity Evaluation of MTBVAC in Newborns in Sub-Saharan AfricaNCT04975178 · 2022-10-17
RECRUITING
Paradoxical Tuberculosis Reactions in Patients Without HIV InfectionNCT04052022 · 2019-12-20
RECRUITING
Vicente Ferrer HIV Cohort StudyNCT02454569 · 2009-09-01
RECRUITING
Safety and Immunogenicity of VPM1002 Vaccination or BCG Revaccination Against TB in Pre-Adolescents Living With and Without HIV in South AfricaNCT05539989 · 2026-12-31
WITHDRAWN
A Clinical Study of the HCMV-TB Vaccine Candidate VIR-1778 in Healthy AdultsNCT07818824 · 2026-11-06
NOT_YET_RECRUITING
A Trial of Stratified Patient-Centered Treatment Regimens for Active TB (SPECTRA-TB)NCT07595042 · 2026-10-30
NOT_YET_RECRUITING
A Study of Daily Rifapentine Combined With Isoniazid (1HP) for Tuberculosis Prevention in Children Less Than 13 Years of Age With and Without HIVNCT07124559 · 2026-10-15
NOT_YET_RECRUITING
STeroids and Enhanced Spectrum Antibiotics for the Treatment of Patients in Africa With Refractory SepsisNCT07332325 · 2026-10-01
NOT_YET_RECRUITING
Rifapentine-Based Shorter Regimens for Tuberculosis and TB Infection in KazakhstanNCT07668479 · 2026-07-01
NOT_YET_RECRUITING
Investigation of the Effects of Oxidized Antigens on the T-Cell Response and the Epigenetic Reprogramming of Neutrophils in Lung Diseases - OXIGENE -NCT07386912 · 2026-02-01
NOT_YET_RECRUITING
Evaluating Next Generation LAM Assays and Molecular Diagnostics (POC and Near POC) for the Diagnosis of TB Among People With Presumptive TB: a Prospective Multicentre Diagnostic Accuracy StudyNCT06019052 · 2025-09-01
NOT_YET_RECRUITING
Scalable Public Health Empowerment, Research, and Education Sites (SPHERES)NCT07126041 · 2025-08-14
NOT_YET_RECRUITING
Development of the Drug and Alcohol Respiratory Health TestNCT06921278 · 2025-04-15
NOT_YET_RECRUITING
Immunocompetent Versus Immunocompromised Tuberculosis (TB) PatientsNCT06709157 · 2024-12-10
NOT_YET_RECRUITING
Targeted Universal TB Testing With Simultaneous TPT Prescribing Among People Living With HIV in South AfricaNCT06739915 · 2024-05-28
COMPLETED
BCG Revaccination Study in Diabetic and Non-Diabetic AdultsNCT06246851 · 2024-04-03
ACTIVE_NOT_RECRUITING
Study to Assess Efficacy and Safety of M72/AS01E-4 Mycobacterium Tuberculosis (Mtb) Vaccine in Adolescents and AdultsNCT06062238 · 2024-03-05
ACTIVE_NOT_RECRUITING
ThiPhiSA: New Pathways to Prevention From Community TB Screening in South AfricaNCT06214910 · 2024-02-20
COMPLETED
Delivering a Multi-disease Screening Tool to Migrant PopulationsNCT05868005 · 2024-01-01
COMPLETED
Evaluating the Potential of Large Language Models for Respiratory Disease ConsultationsNCT06457269 · 2023-10-01
COMPLETED
A Pragmatic Trial With Optimized Dose of Rifampicin and Moxifloxacin for the Treatment of Drug Susceptible Pulmonary TuberculosisNCT05575518 · 2023-08-11
UNKNOWN
Safety and Immune Responses After Vaccination With Two Investigational RNA-based Vaccines Against Tuberculosis in BCG Vaccinated VolunteersNCT05547464 · 2023-07-31
ACTIVE_NOT_RECRUITING
Comparing Treatment Completion Of Daily Rifapentine & Isoniazid For One Month (1HP) To Weekly High Dose Rifapentine & Isoniazid For 3 Months (3HP) In Persons Living With HIV and in Household Contacts of Recently Diagnosed Tuberculosis PatientsNCT05118490 · 2023-07-19
ACTIVE_NOT_RECRUITING
Closing -TB GAPs - for People Living With HIV: TB Guidance for Adaptable Patient-Centered ServiceNCT05342064 · 2023-07-11
ACTIVE_NOT_RECRUITING
Rifapentine and Isoniazid TB Preventive Therapy (3HP) for Children Taking Dolutegravir-based Antiretroviral Treatment (DOLPHIN KIDS)NCT05122767 · 2023-05-24
ACTIVE_NOT_RECRUITING
Pulmonary Rehabilitation in Non-chronic Obstructive Pulmonary Disease Patients.NCT05174741 · 2023-04-01
UNKNOWN
Comparison of Three Different Puncture Techniques in EBUS-TBNANCT05628454 · 2022-11-08
COMPLETED
Alcohol Reduction Among People With TB and HIV in IndiaNCT04230395 · 2022-09-22
ACTIVE_NOT_RECRUITING
TB-CAPT EXULTANT - HIVNCT04568967 · 2022-09-05
COMPLETED
Host Blood RNA Signatures for Diagnosis of TBNCT05542511 · 2022-06-23
ACTIVE_NOT_RECRUITING

Leading sponsors

Disease identity and terminology: MONDO. Trial relationships: ClinicalTrials.gov.